Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

N F Kelland; D J Webb

doi:10.1136/hrt.2006.089250

Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

N F Kelland, D J Webb

Research output: Contribution to journal › Editorial › peer-review

Abstract

The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.

Original language	English
Pages (from-to)	2-4
Number of pages	3
Journal	Heart
Volume	93
Issue number	1
DOIs	https://doi.org/10.1136/hrt.2006.089250
Publication status	Published - Jan 2007

Keywords

Antihypertensive Agents
Clinical Trials as Topic
Endothelin-1
Evidence-Based Medicine
Heart Failure
Humans
Publishing
Receptor, Endothelin A

Access to Document

10.1136/hrt.2006.089250

Clinical trials of endothelin antagonists in heart failureFinal published version, 122 KB

http://heart.bmj.com/content/93/1/2

Cite this

@article{675e9a62005643a6bc5a3b585aff7b39,

title = "Clinical trials of endothelin antagonists in heart failure: publication is good for the public health",

abstract = "The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.",

keywords = "Antihypertensive Agents, Clinical Trials as Topic, Endothelin-1, Evidence-Based Medicine, Heart Failure, Humans, Publishing, Receptor, Endothelin A",

author = "Kelland, {N F} and Webb, {D J}",

year = "2007",

month = jan,

doi = "10.1136/hrt.2006.089250",

language = "English",

volume = "93",

pages = "2--4",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Clinical trials of endothelin antagonists in heart failure

T2 - publication is good for the public health

AU - Kelland, N F

AU - Webb, D J

PY - 2007/1

Y1 - 2007/1

N2 - The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.

AB - The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.

KW - Antihypertensive Agents

KW - Clinical Trials as Topic

KW - Endothelin-1

KW - Evidence-Based Medicine

KW - Heart Failure

KW - Humans

KW - Publishing

KW - Receptor, Endothelin A

U2 - 10.1136/hrt.2006.089250

DO - 10.1136/hrt.2006.089250

M3 - Editorial

C2 - 17170334

VL - 93

SP - 2

EP - 4

JO - Heart

JF - Heart

SN - 1355-6037

IS - 1

ER -

Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

Abstract

Keywords

Access to Document

Fingerprint

Cite this